Association of the aromatase gene with Alzheimer's disease in women
- PMID: 19879925
- DOI: 10.1016/j.neulet.2009.10.089
Association of the aromatase gene with Alzheimer's disease in women
Abstract
Associations have been reported of aromatase polymorphisms with Alzheimer's disease (AD). We studied nine polymorphisms in 207 cases of AD, 23 cases of mild cognitive impairment (MCI) and 233 controls, all from the OPTIMA cohort. We replicated two reported associations and found others. Our findings were consistent between AD and MCI. Further, our results were sex-specific, i.e. there were significant interactions between certain polymorphisms and gender, and the associations with AD were almost entirely in women. Aromatase catalyses the conversion of androgens to estrogens. It is expressed in the human brain. In the hippocampus, it is upregulated in postmenopausal women and is lowered in AD. These sex-specific results are therefore plausible. However, our results now need to be replicated in a larger dataset.
Copyright 2009 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
The sex-specific associations of the aromatase gene with Alzheimer's disease and its interaction with IL10 in the Epistasis Project.Eur J Hum Genet. 2014 Feb;22(2):216-20. doi: 10.1038/ejhg.2013.116. Epub 2013 Jun 5. Eur J Hum Genet. 2014. PMID: 23736221 Free PMC article.
-
CYP19 haplotypes increase risk for Alzheimer's disease.J Med Genet. 2006 Aug;43(8):e42. doi: 10.1136/jmg.2005.039461. J Med Genet. 2006. PMID: 16882736 Free PMC article.
-
Aromatase enzyme and Alzheimer's disease.Minerva Endocrinol. 2006 Mar;31(1):61-73. Minerva Endocrinol. 2006. PMID: 16498364 Review.
-
Genetic variation of CYP19 (aromatase) gene influences age at onset of Alzheimer's disease in women.Dement Geriatr Cogn Disord. 2009;27(6):513-8. doi: 10.1159/000221832. Epub 2009 May 29. Dement Geriatr Cogn Disord. 2009. PMID: 19478482
-
PIN-1 promoter polymorphisms in mild cognitive impairment and susceptibility to Alzheimer's disease: a preliminary report.Aging Clin Exp Res. 2007 Oct;19(5):406-9. doi: 10.1007/BF03324722. Aging Clin Exp Res. 2007. PMID: 18007120
Cited by
-
Steroids and Alzheimer's Disease: Changes Associated with Pathology and Therapeutic Potential.Int J Mol Sci. 2020 Jul 7;21(13):4812. doi: 10.3390/ijms21134812. Int J Mol Sci. 2020. PMID: 32646017 Free PMC article. Review.
-
Brain sex matters: estrogen in cognition and Alzheimer's disease.Mol Cell Endocrinol. 2014 May 25;389(1-2):13-21. doi: 10.1016/j.mce.2013.12.018. Epub 2014 Jan 11. Mol Cell Endocrinol. 2014. PMID: 24418360 Free PMC article. Review.
-
Marked gender differences in progression of mild cognitive impairment over 8 years.Alzheimers Dement (N Y). 2015 Sep 1;1(2):103-110. doi: 10.1016/j.trci.2015.07.001. Alzheimers Dement (N Y). 2015. PMID: 26451386 Free PMC article.
-
Interactions of Aromatase and Seladin-1: A Neurosteroidogenic and Gender Perspective.Transl Neurosci. 2019 Nov 6;10:264-279. doi: 10.1515/tnsci-2019-0043. eCollection 2019. Transl Neurosci. 2019. PMID: 31737354 Free PMC article.
-
Hormonal influences on cognition and risk for Alzheimer's disease.Curr Neurol Neurosci Rep. 2010 Sep;10(5):359-66. doi: 10.1007/s11910-010-0122-6. Curr Neurol Neurosci Rep. 2010. PMID: 20535591 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical